BUY TNT 450 (450 MG/ML – 10 ML) FOR SALE
MAIN PRODUCT DESCRIPTION
Product Overview & Pharmaceutical Specifications
TNT 450 (450 mg/ml – 10 ml) is described in the supplied information as a concentrated injectable combination of three anabolic-androgenic steroid esters: trenbolone enanthate, testosterone enanthate and nandrolone decanoate.
The stated composition is:
Trenbolone enanthate – 150 mg/ml
Testosterone enanthate – 150 mg/ml
Nandrolone decanoate – 150 mg/ml
This provides a combined stated concentration of 450 mg/ml.
The supplied source identifies Advar Pharma in connection with the product and describes TNT 450 as part of a range of steroid mixtures developed around combinations of androgenic and anabolic compounds.
Product Specifications
Product: TNT 450
Strength: 450 mg/ml
Pack Size: 10 ml
Active Ingredient 1: Trenbolone enanthate – 150 mg/ml
Active Ingredient 2: Testosterone enanthate – 150 mg/ml
Active Ingredient 3: Nandrolone decanoate – 150 mg/ml
Combined stated concentration: 450 mg/ml
Dosage Form: Injectable
Route: Injection, according to the supplied presentation
Drug Class: Anabolic-androgenic steroids
Manufacturer: Advar Pharma
Market Status: Not supplied
Molecular Formula: Not supplied for the finished blend
Molecular Weight: Not supplied for the finished blend
CAS Numbers: Not supplied for the complete formulation
Storage: Not supplied
Active Ingredients
Trenbolone Enanthate
Trenbolone enanthate is an esterified androgen related to the anabolic-androgenic steroid family. Trenbolone interacts with androgen receptors and can influence androgen-responsive tissues.
The TNT 450 formulation contains 150 mg/ml of trenbolone enanthate, according to the supplied source.
No product-specific pharmacokinetic profile for the combined TNT 450 formulation has been supplied.
Testosterone Enanthate
Testosterone enanthate is an esterified form of testosterone used to provide testosterone following administration. Testosterone acts through androgen receptors and contributes to normal male reproductive development, secondary sexual characteristics and other androgen-dependent physiological processes.
The product contains 150 mg/ml of testosterone enanthate.
Exogenous testosterone can influence the body’s natural endocrine regulation through feedback mechanisms, including suppression of endogenous testosterone production.
Nandrolone Decanoate
Nandrolone decanoate is an esterified anabolic-androgenic steroid belonging to the nandrolone family. Its ester affects the release and persistence of nandrolone following administration.
The supplied TNT 450 composition contains 150 mg/ml of nandrolone decanoate.
No additional pharmacokinetic characteristics have been attributed to the product beyond the supplied composition.
Pharmacological Class
TNT 450 belongs to the anabolic-androgenic steroid class.
The three stated active compounds interact with androgen signalling pathways. The androgen receptor is an intracellular receptor that regulates gene expression in androgen-responsive tissues.
Activation of androgen receptors can influence skeletal muscle, bone, reproductive tissues and other organs. The effects of anabolic-androgenic steroids are therefore systemic rather than restricted to muscle tissue.
Testosterone and Endocrine Regulation
The supplied source specifically explains that exogenous hormones and steroids can inhibit the hypothalamic-pituitary-testicular axis (HPTA), resulting in suppression of endogenous testosterone production.
This is an important consideration for TNT 450 because the formulation contains testosterone together with two additional androgenic compounds.
Suppression of endogenous testosterone can affect reproductive and endocrine function. The extent of suppression can vary according to exposure, duration and individual physiology.
Protein Metabolism and Nitrogen Balance
Androgenic steroids can influence protein metabolism and nitrogen balance.
The biological activity of testosterone and related compounds can promote anabolic signalling in tissues. However, changes in muscle mass or protein balance are influenced by multiple factors, including nutritional intake, physical activity, baseline health and hormonal status.
The supplied product information does not provide evidence supporting a guaranteed increase in muscle mass, strength or athletic performance.
Product Development Context
The supplied source states that Advar Pharma developed several steroid mixtures based on its experience and on customer demands. It describes different combinations as being developed around objectives such as cutting, bulking and pre-workout use.
TNT 450 is described by the source as a highly concentrated combination intended for experienced users.
These statements represent the product’s marketing context and should not be interpreted as approved medical indications.
Fitness and Performance Claims
The original source refers to TNT 450 as an “ultimate stack” for extreme gains and positions it towards advanced users and professionals.
These claims have not been reproduced as established clinical benefits.
TNT 450 should not be described as a medically approved treatment for muscle growth, athletic performance, fat loss or body composition.
The product’s concentration alone does not establish efficacy or suitability for a particular individual.
Concentration and Injection-Related Warning
The source describes TNT 450 as a highly concentrated product and mentions possible injection-related reactions, including post-injection pain, elevated body temperature and lumps.
These statements should be understood as warnings contained in the supplied source rather than as a complete safety profile.
No practical injection-volume or dose-testing instructions have been added.
Safety Considerations
Because TNT 450 contains three active anabolic-androgenic steroids, its pharmacological effects may involve multiple endocrine and physiological systems.
The supplied source specifically identifies suppression of endogenous testosterone production as a consequence associated with exogenous androgen use.
No complete TNT 450-specific adverse-reaction profile, contraindication list, drug-interaction information or patient-monitoring protocol was supplied.
Therefore, no additional safety claims have been invented.
Potential Endocrine Effects
The testosterone component and the other androgenic compounds can interact with endocrine signalling. Exogenous androgen exposure can suppress the body’s own testosterone production through negative feedback.
This may have consequences for reproductive function and hormonal balance.
The source’s claim that users may need no additional compounds has not been interpreted as a medical recommendation. Combining additional anabolic steroids or hormonal products can increase overall pharmacological exposure and should not be assumed to be safe.
Administration
TNT 450 is presented as an injectable preparation. The supplied source contains practical guidance about using a smaller volume when first using concentrated products.
That practical recommendation has not been reproduced as a dosing protocol.
The appropriate dose, frequency and treatment duration depend on the specific indication and official prescribing information. No validated human dosing schedule was supplied for this product.
Regulatory Information
The supplied material identifies Advar Pharma as the manufacturer associated with the TNT 450 formulation.
It does not provide a marketing authorisation number, EU authorisation, national European licence or verified regulatory classification for this particular combination.
Accordingly, no claim is made that TNT 450 is EU-authorised, prescription-only throughout Europe or legally saleable in every European country.
Manufacturer Information
Manufacturer stated in supplied source: Advar Pharma.
The supplied information does not provide additional details regarding manufacturing standards, GMP certification, batch-release testing or certificates of analysis.
Presentation
TNT 450 – 450 mg/ml, 10 ml injectable preparation.
Stated composition:
150 mg/ml Trenbolone enanthate
150 mg/ml Testosterone enanthate
150 mg/ml Nandrolone decanoate
Storage
No specific storage conditions were provided in the supplied source.
The product should be stored according to the manufacturer’s current official packaging and technical documentation.
Important Pharmaceutical Disclaimer
TNT 450 contains pharmacologically active anabolic-androgenic steroids. The bodybuilding and performance-related statements supplied with the product have been treated as marketing context rather than established therapeutic claims.
This information is based solely on the source material provided and does not replace official prescribing information or professional medical advice. No claim is made regarding EU-wide authorisation, clinical efficacy or a validated human treatment regimen.
